We are live on ! Find out more
BIOC

Biocept, Inc.
BIOC

Delisted

BIOC was delisted on the 24th of October, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of BIOC yet.

BIOC Hedge Fund Activity: Q4 2023 in Review

0 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q4 2023, worth a combined $0 — down 100% from $218K a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of BIOC and 0 opened new positions — a net loss of 13 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Alyeska Investment Group, exiting entirely with an estimated $147K sold.

  • 0 institutional investors held Biocept, Inc. (BIOC) as of Q4 2023, down from 13 in Q3 2023.
  • Funds reported $0 of Biocept, Inc. stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Biocept, Inc. positions in Q4 2023 and 13 closed out, a net change of -13 holders.
  • The largest Biocept, Inc. seller in Q4 2023 was Alyeska Investment Group, an estimated $147K sold.

Based on aggregated 13F filings for Q4 2023.